Epilepsy refers to a heterogeneous group of disorders that are associated with a wide range of pathogenic mechanisms, seizure manifestations, comorbidity profiles, and therapeutic responses. These characteristics are all influenced quite significantly by sex. As with other conditions exhibiting such patterns, sex differences in epilepsy are thought to arise-at the most fundamental level-from the "organizational" and "activational" effects of sex hormones as well as from the direct actions of the sex chromosomes. However, our understanding of the specific molecular, cellular, and network level processes responsible for mediating sex differences in epilepsy remains limited. Because increasing evidence suggests that epigenetic mechanisms are involved both in epilepsy and in brain sexual dimorphism, we make the case here that analyzing epigenetic regulation will provide novel insights into the basis for sex differences in epilepsy.
Introduction
Epilepsy refers to a broad spectrum of disease states, including both genetic and acquired disorders, which can be associated with varying pathogenic mechanisms, seizure patterns and frequencies, comorbid conditions (e.g., autism and other neurodevelopmental and neuropsychiatric disorders), therapeutic responses and toxicities (e.g., alterations in sex hormone metabolism), and clinical outcomes. Clinical observations and translational research efforts suggest that these features are all influenced to a significant degree by sex (Veliskova and Desantis, 2013; Perucca et al., 2014b; Savic and Engel, 2014; Kight and McCarthy, 2014; Giorgi et al., 2014; Akman et al., 2014; van Luijtelaar et al., 2014; Scharfman and MacLusky, 2014; Koppel and Harden, 2014; Reddy, 2014; Perucca et al., 2014a; Pitkänen, et al., 2014) . For example, epidemiological and genetic studies have revealed that some syndromes are more common in females, including those which are thought to be X chromosome-linked (e.g., Aicardi syndrome, Rett Neurobiology of Disease 72 (2014) 210-216 
